March/April 2022
Biopharma Asia
March/April 2022 | Volume 11 Issue 2
Data as an Asset: What Does this Mean to You?
Christos Varsakelis, Team Lead Artificial Intelligence/Machine Learning, The Janssen Pharm...
Developing a Leading Edge with PAT
Martin Gadsby, Owner, Optimal Industrial Automation Ltd
Risk-Based Extractable Data Assessment and its Application to the Evaluation of Materials ...
Ping Wang Ph.D., MBA, Scientific Director, Janssen
Supply Chain Security Risks
Brian Johnson, Senior Director of Supply Chain Security, Pfizer Pharmaceuticals / Chair o...
Applications of SFC in Pharmaceutical Analysis
Gregory Webster, Senior Principal Research Scientist, AbbVie Inc
Transforming Scientists into Drug Developers
Clive Glover, General Manager, Gene Therapy, Pall James Taylor, Co-founder and GM, Precisi...
















